CytoSorb safety registry for clot-fighting medicine removal
Part of Blood & lymphatic, Injuries & trauma clinical trials.
This registry collects information on people who use CytoSorb to remove clot-fighting medicines from the blood. It’s mainly meant to track safety and how quickly the removal works, which may help improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must use CytoSorb to remove an antithrombotic (clot-fighting) treatment from your blood
- You must agree to provide informed consent to join this registry and be followed going forward
- CytoSorb must be used only for antithrombotic removal, not for any other purpose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information about critically ill patients who receive the CytoSorb 300 mL blood treatment. It may help doctors better understand when the treatment works best and when it should not be used.
This study tracks patients who had cardiac surgery using a specific Medtronic heart-surgery device. It mainly collects real-world data to help understand outcomes, and you may be included if you give consent and are not in another device/drug study that could affect the results.
This study tests a special filter (called Cytosorb) that may reduce bleeding during heart surgery by capturing the blood thinner ticagrelor from your blood. If you take ticagrelor and are scheduled for heart surgery with a bypass machine, this filter could help lower your risk of bleeding.
This trial tests a device called CytoSorb that filters the blood to reduce inflammation in patients with sudden worsening of chronic liver disease. It may help support organ function and recovery.
This trial surveys surgeons about how they use hemostatic agents (medications that stop bleeding during surgery). It aims to understand current practices and improve patient safety.
This trial tests a device that filters the blood during urgent heart surgery. It may help patients who take blood thinners by reducing bleeding risks during surgery.
Hear when a new Hemorrhage, Surgical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.